TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 96 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $9,000 | -10.0% | 17,722 | +145.4% | 0.00% | – |
Q1 2019 | $10,000 | – | 7,222 | +120266.7% | 0.00% | – |
Q4 2018 | $0 | – | 6 | -72.7% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 22 | -100.0% | 0.00% | -100.0% |
Q2 2018 | $322,000 | +585.1% | 90,131 | +483.9% | 0.00% | – |
Q1 2018 | $47,000 | -89.4% | 15,435 | -78.0% | 0.00% | -100.0% |
Q4 2017 | $442,000 | -46.7% | 70,178 | -42.2% | 0.00% | -62.5% |
Q3 2017 | $830,000 | +325.6% | 121,364 | +471.1% | 0.01% | +300.0% |
Q1 2017 | $195,000 | +4775.0% | 21,250 | +1987.4% | 0.00% | – |
Q4 2016 | $4,000 | -96.7% | 1,018 | -96.8% | 0.00% | -100.0% |
Q3 2016 | $122,000 | -52.9% | 31,929 | -47.0% | 0.00% | -66.7% |
Q2 2016 | $259,000 | -25.4% | 60,277 | -19.5% | 0.00% | -40.0% |
Q1 2016 | $347,000 | -27.1% | 74,840 | +57.6% | 0.01% | -16.7% |
Q4 2015 | $476,000 | -49.0% | 47,482 | +141.1% | 0.01% | -53.8% |
Q2 2015 | $934,000 | +178.0% | 19,696 | +114.7% | 0.01% | +160.0% |
Q1 2015 | $336,000 | +57.7% | 9,172 | +71.0% | 0.01% | +66.7% |
Q4 2014 | $213,000 | +42.0% | 5,364 | -51.6% | 0.00% | +50.0% |
Q2 2014 | $150,000 | +38.9% | 11,093 | +11.4% | 0.00% | 0.0% |
Q1 2014 | $108,000 | – | 9,956 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |